NASDAQ:CLXT
Delisted
Calyxt Inc Stock News
$6.30
+0 (+0%)
At Close: Aug 30, 2023
Calyxt and Cibus Announce Definitive Merger Agreement to Create Industry-Leading Precision Gene Editing and Trait Licensing Company
06:30am, Tuesday, 17'th Jan 2023
– The merger will bring together the technology platforms and facilities of two pioneering companies to create a leader in precision gene editing focused on driving sustainable agriculture and the a
Calyxt, Inc. (CLXT) Q3 2022 Earnings Call Transcript
11:07am, Sunday, 06'th Nov 2022
Calyxt, Inc. (NASDAQ:CLXT ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants William Koschak - CFO Michael Carr - President and CEO Operator Good afternoon, ladies and
Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022
02:41pm, Friday, 04'th Nov 2022 Benzinga
Upgrades
Citigroup upgraded the previous rating for Advanced Energy Industries Inc (NASDAQ:AEIS) from Neutral to Buy. For the third quarter, Advanced Energy Indus had an EPS of $2.12, compared to yea
Calyxt (CLXT) Reports Q3 Loss, Misses Revenue Estimates
06:48pm, Thursday, 03'rd Nov 2022
Calyxt (CLXT) delivered earnings and revenue surprises of 13.33% and 86%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Bears are Losing Control Over Calyxt (CLXT), Here's Why It's a 'Buy' Now
01:55pm, Wednesday, 31'st Aug 2022 Zacks Investment Research
Calyxt (CLXT) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a tren
Why Cepton Is Trading Higher By 19%; Here Are 28 Stocks Moving Premarket
11:14am, Wednesday, 31'st Aug 2022 Benzinga
Gainers
Software Acquisition Group Inc. III (NASDAQ: NOGN) shares rose 80.1% to $6.04 in pre-market trading after dropping over 65% on Tuesday.
Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares rose 3
Calyxt, Inc. (CLXT) CEO Michael Carr on Q2 2022 Results - Earnings Call Transcript
01:45pm, Sunday, 07'th Aug 2022
Calyxt, Inc. (NASDAQ:CLXT ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Bill Koschak - Chief Financial Officer Michael Carr - President and Chief Executive Officer
Calyxt (CLXT) Reports Q2 Loss, Tops Revenue Estimates
10:25pm, Thursday, 04'th Aug 2022 Zacks Investment Research
Calyxt (CLXT) delivered earnings and revenue surprises of 6.67% and 36.67%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Calyxt to Present at the Canaccord Genuity 42nd Annual Growth Conference
07:00am, Thursday, 28'th Jul 2022
ROSEVILLE, Minn. , July 28, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that Michael A.
Calyxt to Host Second Quarter 2022 Financial Results Conference Call and Webcast on Thursday, August 4, 2022, at 4:30 p.m. Eastern Time
07:00am, Thursday, 21'st Jul 2022
ROSEVILLE, Minn. , July 21, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, will host a conference call and webcast on Thursday, August 4, 2022, at 4:3
Why Qudian Shares Jumped Over 40%; Here Are 73 Biggest Movers From Yesterday
08:35am, Tuesday, 19'th Jul 2022 Benzinga
Gainers
AMTD Digital Inc. (NYSE: HKD) climbed 71.5% to close at $27.80 on Monday after gaining 108% on Friday. The company priced its IPO at $7 per share.
SKYX Platforms Corp. (NASDAQ: SKYX) jumped
Calyxt, Inc. (CLXT) CEO Michael Carr on Q1 2022 Results - Earnings Call Transcript
03:07am, Sunday, 08'th May 2022
Calyxt, Inc. (NASDAQ:CLXT ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Bill Koschak - Chief Financial Officer Michael Carr - President and Chief Executive Officer Con
Calyxt (CLXT) Reports Q1 Loss, Misses Revenue Estimates
09:45pm, Thursday, 05'th May 2022 Zacks Investment Research
Calyxt (CLXT) delivered earnings and revenue surprises of 22.22% and 96.24%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Calyxt to Host First Quarter 2022 Financial Results Conference Call and Webcast on Thursday, May 5, 2022, at 4:30 p.m. Eastern Time
07:08am, Thursday, 21'st Apr 2022
ROSEVILLE, Minn. , April 21, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, will host a conference call and webcast on Thursday, May 5, 2022, at 4:30 p.m.
Calyxt Switches Gears Again, But The Cash Clock Keeps Ticking Down
02:18am, Friday, 01'st Apr 2022
Calyxt is now on to its third business plan, pivoting from gene-edited seed traits to synthetic biology. The company is looking to produce molecules of interest to pharmaceutical, nutraceutical, and c